263 related articles for article (PubMed ID: 21556249)
1. Growth factor receptors and apoptosis regulators: signaling pathways, prognosis, chemosensitivity and treatment outcomes of breast cancer.
Sarkar S; Mandal M
Breast Cancer (Auckl); 2009 Aug; 3():47-60. PubMed ID: 21556249
[TBL] [Abstract][Full Text] [Related]
2. Emerging biomarkers and new understanding of traditional markers in personalized therapy for breast cancer.
Dowsett M; Dunbier AK
Clin Cancer Res; 2008 Dec; 14(24):8019-26. PubMed ID: 19088018
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
[TBL] [Abstract][Full Text] [Related]
4. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers for breast cancer.
Beenken SW; Bland KI
Minerva Chir; 2002 Aug; 57(4):437-48. PubMed ID: 12145573
[TBL] [Abstract][Full Text] [Related]
6. Biochemical markers in breast cancer: which ones are clinically useful?
Duffy MJ
Clin Biochem; 2001 Jul; 34(5):347-52. PubMed ID: 11522269
[TBL] [Abstract][Full Text] [Related]
7. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
8. Triple-negative breast cancer: current state of the art.
Rastelli F; Biancanelli S; Falzetta A; Martignetti A; Casi C; Bascioni R; Giustini L; Crispino S
Tumori; 2010; 96(6):875-88. PubMed ID: 21388048
[TBL] [Abstract][Full Text] [Related]
9. A personalized approach to cancer treatment: how biomarkers can help.
Duffy MJ; Crown J
Clin Chem; 2008 Nov; 54(11):1770-9. PubMed ID: 18801934
[TBL] [Abstract][Full Text] [Related]
10. Age-associated biomarker profiles of human breast cancer.
Eppenberger-Castori S; Moore DH; Thor AD; Edgerton SM; Kueng W; Eppenberger U; Benz CC
Int J Biochem Cell Biol; 2002 Nov; 34(11):1318-30. PubMed ID: 12200028
[TBL] [Abstract][Full Text] [Related]
11. Value of epidermal growth factor receptor, HER2, p53, and steroid receptors in predicting the efficacy of tamoxifen in high-risk postmenopausal breast cancer patients.
Knoop AS; Bentzen SM; Nielsen MM; Rasmussen BB; Rose C
J Clin Oncol; 2001 Jul; 19(14):3376-84. PubMed ID: 11454885
[TBL] [Abstract][Full Text] [Related]
12. Potential prognostic tumor biomarkers in triple-negative breast carcinoma.
Peng Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Oct; 44(5):666-72. PubMed ID: 23073572
[TBL] [Abstract][Full Text] [Related]
13. Co-expression of steroid receptors (estrogen receptor alpha and/or progesterone receptors) and Her-2/neu: Clinical implications.
Ciocca DR; Gago FE; Fanelli MA; Calderwood SK
J Steroid Biochem Mol Biol; 2006 Dec; 102(1-5):32-40. PubMed ID: 17049840
[TBL] [Abstract][Full Text] [Related]
14. Differences in clinical importance of Bcl-2 in breast cancer according to hormone receptors status or adjuvant endocrine therapy.
Honma N; Horii R; Ito Y; Saji S; Younes M; Iwase T; Akiyama F
BMC Cancer; 2015 Oct; 15():698. PubMed ID: 26472348
[TBL] [Abstract][Full Text] [Related]
15. Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance.
Taneja P; Maglic D; Kai F; Zhu S; Kendig RD; Fry EA; Inoue K
Clin Med Insights Oncol; 2010 Apr; 4():15-34. PubMed ID: 20567632
[TBL] [Abstract][Full Text] [Related]
16. Tumor markers in breast cancer--evaluation of their clinical usefulness.
Marić P; Ozretić P; Levanat S; Oresković S; Antunac K; Beketić-Oresković L
Coll Antropol; 2011 Mar; 35(1):241-7. PubMed ID: 21661378
[TBL] [Abstract][Full Text] [Related]
17. Predictive markers in breast and other cancers: a review.
Duffy MJ
Clin Chem; 2005 Mar; 51(3):494-503. PubMed ID: 15637130
[TBL] [Abstract][Full Text] [Related]
18. Validated biomarkers: The key to precision treatment in patients with breast cancer.
Duffy MJ; O'Donovan N; McDermott E; Crown J
Breast; 2016 Oct; 29():192-201. PubMed ID: 27521224
[TBL] [Abstract][Full Text] [Related]
19. Molecular Biomarkers for Contemporary Therapies in Hormone Receptor-Positive Breast Cancer.
Freelander A; Brown LJ; Parker A; Segara D; Portman N; Lau B; Lim E
Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33671468
[TBL] [Abstract][Full Text] [Related]
20. Current Biomarkers for Precision Medicine in Breast Cancer.
Ahn SK; Jung SY
Adv Exp Med Biol; 2021; 1187():363-379. PubMed ID: 33983588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
